drugset / Trial / NCT02473393
A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis
RandomizedParallel-groupOpen-labelTreatment
Summary
To assess safety, efficacy and pharmacokinetics of multiple dosesin patients with Bacterial Enteritis caused by Clostridium difficile infection(CDI) or Enteric infection.
Timeline
- Start
- 2015-08-20
- Primary completion
- 2017-03-14
- Completion
- 2017-03-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OPS-2071 | Small molecule | 25 mg | Oral |
| Subject | OPS-2071 | Small molecule | 50 mg | Oral |
| Subject | OPS-2071 | Small molecule | 100 mg | Oral |
| Subject | OPS-2071 | Small molecule | 200 mg | Oral |